Jump to ContentJump to Main Navigation
Show Summary Details
Weitere Optionen …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Wissenschaftlicher Beirat: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
Alle Formate und Preise
Weitere Optionen …
Band 385, Heft 9

Hefte

Non-muscle α-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1)

Ulla Magdolen
  • Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger str. 22, D-81675 München, Germany
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Florian Schroeck
  • Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger str. 22, D-81675 München, Germany
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Sabine Creutzburg
  • Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger str. 22, D-81675 München, Germany
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Manfred Schmitt
  • Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger str. 22, D-81675 München, Germany
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Viktor Magdolen
  • Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger str. 22, D-81675 München, Germany
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
Online erschienen: 01.06.2005 | DOI: https://doi.org/10.1515/BC.2004.105

Abstract

PAI-1 modulates many biological processes involving fibrinolysis, cell migration or tissue remodelling. In addition to inhibiting serine proteases (mainly tPA and uPA), PAI-1 interacts with vitronectin (Vn), fibrin or α(1)-acid glycoprotein, interactions which are important for PAI-1-mediated effects in inflammation, tumor invasion and metastasis. To further identify proteins interacting with PAI-1, the yeast two-hybrid strategy was employed. Screening of a human placenta cDNA library identified – in addition to the C-terminal region of cytokeratin 18 (CK18182-430) – a large C-terminal fragment of α-actinin-4 (Act-4) as a binding partner for PAI-1. Two different cDNA clones encoding Act-4287-911 and Act-4330-911, respectively, were isolated. An Act-4330-911/GST-fusion protein, but not GST alone, was immunoprecipitated together with active PAI-1. In solid phase binding assays, active wild-type PAI-1 as well as the PAI-1 variant Q123K (which does not interact with multimeric Vn) was found to bind to Act-4330-911/GST. Latent PAI-1, latent Q123K, and the inactive PAI-1 variant Q55P did not display any binding activity. Act-4 is mainly present intracellularly and is involved in cellular motility via interaction with the actin cytoskeleton, thus probably affecting the metastatic potential of tumor cells. However, an extracellular Act-4-derived fragment (mactinin) has previously been identified, which (i) is generated by proteolytic action of uPA, (ii) displays significant chemotactic activity for monocytes, and (iii) promotes monocyte/macrophage maturation. We suggest that PAI-1, via interaction with both Act-4 and uPA, may function as a modulator of this mononuclear phagocyte response, not only in inflammation but also in tumor invasion and metastasis.

Keywords: α-actinin; plasminogen activator inhibitor type 1; yeast two-hybrid system

Artikelinformationen

Erhalten: May 6, 2004

Angenommen: July 5, 2004

Online erschienen: 01.06.2005

Erschienen im Druck: 01.09.2004


Quellenangabe: Biological Chemistry, Band 385, Heft 9, Seiten 801–808, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2004.105.

Zitat exportieren

Zitierende Artikel

Hier finden Sie eine Übersicht über alle Crossref-gelisteten Publikationen, in denen dieser Artikel zitiert wird. Um automatisch über neue Zitierungen dieses Artikels informiert zu werden, aktivieren Sie einfach oben auf dieser Seite den „E-Mail-Alert: Neu zitiert“.

[1]
Wei Peng, Chao Tong, Lei Li, Chengyu Huang, Yuxin Ran, Xuehai Chen, Yuxiang Bai, Yamin Liu, Jianlin Zhao, Bin Tan, Xiaofang Luo, Hao Wang, Li Wen, Chen Zhang, Hua Zhang, Yubin Ding, Hongbo Qi, and Philip N. Baker
The FASEB Journal, 2019, Jahrgang 33, Nummer 5, Seite 6327
[2]
Ying-Hua Chang, Shu-Hui Lee, Hua-Chien Chang, Yau-Lin Tseng, Wu-Wei Lai, Chen-Chung Liao, Yeou-Guang Tsay, and Pao-Chi Liao
Journal of Proteome Research, 2012, Jahrgang 11, Nummer 11, Seite 5167
[3]
Yufei Gao, Guanghu Li, Liankun Sun, Yichun He, Xiaoyan Li, Zhi Sun, Jihan Wang, Yang Jiang, and Jingwei Shi
BMC Cancer, 2015, Jahrgang 15, Nummer 1
[4]
Naveed Hussain, Winfried Krueger, Jonathan Covault, Stephen Walsh, Henry R Kranzler, and Cheryl Oncken
Pediatric Research, 2008, Jahrgang 64, Nummer 2, Seite 147
[5]
Vladimir N. Babakov, Olga A. Petukhova, Lidia V. Turoverova, Irina V. Kropacheva, Dmitri G. Tentler, Anastasia V. Bolshakova, Ekaterina P. Podolskaya, Karl-Eric Magnusson, and George P. Pinaev
Experimental Cell Research, 2008, Jahrgang 314, Nummer 5, Seite 1030
[6]
Cheri Hampton and Kenneth Taylor
AfCS-Nature Molecule Pages, 2006
[7]
Harris Bernstein, Hana Holubec, Carol Bernstein, Natalia Ignatenko, Eugene Gerner, Katerina Dvorak, David Besselsen, Lois Ramsey, Monique DallʼAgnol, Karen Ann Blohm-Mangone, Jose Padilla-Torres, Haiyan Cui, Harinder Garewal, and Claire Margaret Payne
Inflammatory Bowel Diseases, 2006, Jahrgang 12, Nummer 4, Seite 278
[8]
Maria V Barbolina, Brian P Adley, David L Kelly, Angela J Fought, Denise M Scholtens, Lonnie D Shea, and M Sharon Stack
Laboratory Investigation, 2008, Jahrgang 88, Nummer 6, Seite 602

Kommentare (0)